Ocugen Capex To Operating Cash Flow vs Ev To Sales Analysis

OCGN Stock

USD 0.83 0 0.12%

Ocugen financial indicator trend analysis is much more than just breaking down Ocugen Inc prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Ocugen Inc is a good investment. Please check the relationship between Ocugen Capex To Operating Cash Flow and its Ev To Sales accounts. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Ocugen Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.

Capex To Operating Cash Flow vs Ev To Sales

Capex To Operating Cash Flow vs Ev To Sales Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Ocugen Inc Capex To Operating Cash Flow account and Ev To Sales. At this time, the significance of the direction appears to have weak relationship.

The correlation between Ocugen's Capex To Operating Cash Flow and Ev To Sales is 0.38. Overlapping area represents the amount of variation of Capex To Operating Cash Flow that can explain the historical movement of Ev To Sales in the same time period over historical financial statements of Ocugen Inc, assuming nothing else is changed. The correlation between historical values of Ocugen's Capex To Operating Cash Flow and Ev To Sales is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Capex To Operating Cash Flow of Ocugen Inc are associated (or correlated) with its Ev To Sales. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Ev To Sales has no effect on the direction of Capex To Operating Cash Flow i.e., Ocugen's Capex To Operating Cash Flow and Ev To Sales go up and down completely randomly.

Correlation Coefficient

0.38

Relationship Direction	Positive
Relationship Strength	Very Weak

View All Relationships

Capex To Operating Cash Flow

Ev To Sales

The Enterprise Value to Sales ratio, a valuation metric used to compare the value of a company, including debt and excluding cash, to its sales revenue.

Most indicators from Ocugen's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Ocugen Inc current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Ocugen Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.

At this time, Ocugen's Selling General Administrative is very stable compared to the past year. As of the 9th of January 2025, Enterprise Value is likely to grow to about 171.3 M, while Issuance Of Capital Stock is likely to drop about 22.7 M.

Ocugen fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Common Stock Total Equity	Common Stock Shares Outstanding	Non Current Liabilities Total	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Intangible Assets	Common Stock	Short Long Term Debt Total	Current Deferred Revenue	Other Assets	Long Term Debt
Total Assets		0.58	0.66	0.88	0.39	-0.93	-0.42	0.76	0.97	0.41	0.58	0.98	0.69	0.71	-0.47	-0.22	0.25	-0.31	0.4	0.98	-0.36	0.66	0.63	0.5	0.24	0.51
Other Current Liab	0.58		0.47	0.32	0.16	-0.46	-0.08	0.51	0.49	0.27	0.42	0.55	0.49	0.52	0.08	-0.28	-0.02	0.22	0.17	0.56	0.09	0.46	0.54	0.38	0.18	0.49
Total Current Liabilities	0.66	0.47		0.58	0.9	-0.4	-0.72	0.68	0.51	0.91	0.95	0.54	0.78	0.89	-0.34	-0.16	0.34	-0.12	0.9	0.55	-0.39	0.84	0.96	0.85	-0.32	0.87
Total Stockholder Equity	0.88	0.32	0.58		0.37	-0.85	-0.41	0.59	0.88	0.35	0.53	0.88	0.71	0.67	-0.82	-0.05	0.12	-0.72	0.38	0.88	-0.59	0.67	0.55	0.47	0.09	0.44
Property Plant And Equipment Net	0.39	0.16	0.9	0.37		-0.12	-0.75	0.35	0.25	0.99	0.91	0.24	0.65	0.79	-0.27	-0.21	0.33	-0.09	1.0	0.24	-0.33	0.75	0.88	0.76	-0.4	0.83
Net Debt	-0.93	-0.46	-0.4	-0.85	-0.12		0.22	-0.63	-0.99	-0.13	-0.31	-0.98	-0.5	-0.48	0.44	0.26	-0.18	0.35	-0.13	-0.97	0.27	-0.44	-0.36	-0.25	-0.44	-0.25
Retained Earnings	-0.42	-0.08	-0.72	-0.41	-0.75	0.22		-0.42	-0.31	-0.69	-0.7	-0.32	-0.53	-0.62	0.32	0.39	-0.48	0.17	-0.75	-0.31	0.58	-0.6	-0.61	-0.79	0.52	-0.52
Accounts Payable	0.76	0.51	0.68	0.59	0.35	-0.63	-0.42		0.67	0.38	0.48	0.72	0.4	0.46	-0.24	-0.08	0.37	-0.06	0.36	0.73	-0.2	0.41	0.54	0.53	-0.15	0.4
Cash	0.97	0.49	0.51	0.88	0.25	-0.99	-0.31	0.67		0.26	0.44	0.99	0.6	0.6	-0.48	-0.26	0.19	-0.36	0.26	0.99	-0.33	0.55	0.49	0.36	0.37	0.38
Non Current Assets Total	0.41	0.27	0.91	0.35	0.99	-0.13	-0.69	0.38	0.26		0.93	0.26	0.65	0.81	-0.21	-0.23	0.33	-0.02	0.99	0.26	-0.23	0.75	0.91	0.78	-0.33	0.87
Non Currrent Assets Other	0.58	0.42	0.95	0.53	0.91	-0.31	-0.7	0.48	0.44	0.93		0.44	0.86	0.95	-0.33	-0.13	0.27	-0.13	0.92	0.46	-0.42	0.92	0.97	0.9	-0.23	0.94
Cash And Short Term Investments	0.98	0.55	0.54	0.88	0.24	-0.98	-0.32	0.72	0.99	0.26	0.44		0.61	0.6	-0.47	-0.25	0.2	-0.34	0.25	1.0	-0.33	0.56	0.5	0.39	0.32	0.38
Common Stock Total Equity	0.69	0.49	0.78	0.71	0.65	-0.5	-0.53	0.4	0.6	0.65	0.86	0.61		0.97	-0.52	-0.1	-0.1	-0.37	0.67	0.63	-0.62	0.99	0.86	0.75	-0.06	0.84
Common Stock Shares Outstanding	0.71	0.52	0.89	0.67	0.79	-0.48	-0.62	0.46	0.6	0.81	0.95	0.6	0.97		-0.43	-0.16	0.09	-0.24	0.8	0.62	-0.52	0.99	0.95	0.81	-0.08	0.91
Non Current Liabilities Total	-0.47	0.08	-0.34	-0.82	-0.27	0.44	0.32	-0.24	-0.48	-0.21	-0.33	-0.47	-0.52	-0.43		-0.2	0.06	0.97	-0.27	-0.48	0.71	-0.49	-0.3	-0.31	0.2	-0.24
Other Current Assets	-0.22	-0.28	-0.16	-0.05	-0.21	0.26	0.39	-0.08	-0.26	-0.23	-0.13	-0.25	-0.1	-0.16	-0.2		0.0	-0.25	-0.21	-0.18	-0.17	-0.11	-0.15	-0.2	-0.02	-0.16
Other Stockholder Equity	0.25	-0.02	0.34	0.12	0.33	-0.18	-0.48	0.37	0.19	0.33	0.27	0.2	-0.1	0.09	0.06	0.0		0.15	0.32	0.2	0.01	-0.02	0.18	0.31	-0.03	0.06
Total Liab	-0.31	0.22	-0.12	-0.72	-0.09	0.35	0.17	-0.06	-0.36	-0.02	-0.13	-0.34	-0.37	-0.24	0.97	-0.25	0.15		-0.09	-0.35	0.66	-0.33	-0.1	-0.14	0.14	-0.06
Property Plant And Equipment Gross	0.4	0.17	0.9	0.38	1.0	-0.13	-0.75	0.36	0.26	0.99	0.92	0.25	0.67	0.8	-0.27	-0.21	0.32	-0.09		0.25	-0.34	0.76	0.89	0.77	-0.39	0.84
Total Current Assets	0.98	0.56	0.55	0.88	0.24	-0.97	-0.31	0.73	0.99	0.26	0.46	1.0	0.63	0.62	-0.48	-0.18	0.2	-0.35	0.25		-0.36	0.58	0.52	0.4	0.33	0.4
Intangible Assets	-0.36	0.09	-0.39	-0.59	-0.33	0.27	0.58	-0.2	-0.33	-0.23	-0.42	-0.33	-0.62	-0.52	0.71	-0.17	0.01	0.66	-0.34	-0.36		-0.6	-0.34	-0.46	0.4	-0.24
Common Stock	0.66	0.46	0.84	0.67	0.75	-0.44	-0.6	0.41	0.55	0.75	0.92	0.56	0.99	0.99	-0.49	-0.11	-0.02	-0.33	0.76	0.58	-0.6		0.91	0.8	-0.13	0.89
Short Long Term Debt Total	0.63	0.54	0.96	0.55	0.88	-0.36	-0.61	0.54	0.49	0.91	0.97	0.5	0.86	0.95	-0.3	-0.15	0.18	-0.1	0.89	0.52	-0.34	0.91		0.83	-0.19	0.95
Current Deferred Revenue	0.5	0.38	0.85	0.47	0.76	-0.25	-0.79	0.53	0.36	0.78	0.9	0.39	0.75	0.81	-0.31	-0.2	0.31	-0.14	0.77	0.4	-0.46	0.8	0.83		-0.38	0.8
Other Assets	0.24	0.18	-0.32	0.09	-0.4	-0.44	0.52	-0.15	0.37	-0.33	-0.23	0.32	-0.06	-0.08	0.2	-0.02	-0.03	0.14	-0.39	0.33	0.4	-0.13	-0.19	-0.38		-0.11
Long Term Debt	0.51	0.49	0.87	0.44	0.83	-0.25	-0.52	0.4	0.38	0.87	0.94	0.38	0.84	0.91	-0.24	-0.16	0.06	-0.06	0.84	0.4	-0.24	0.89	0.95	0.8	-0.11

Click cells to compare fundamentals

Ocugen Account Relationship Matchups

Ocugen fundamental ratios Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	27.4M	105.8M	108.6M	64.5M	74.2M	48.2M
Other Current Liab	2.9M	4.0M	8.3M	2.8M	3.2M	2.4M
Total Current Liabilities	3.6M	7M	18.5M	17.1M	19.7M	20.6M
Total Stockholder Equity	21.6M	95.8M	84.1M	40.6M	46.6M	49.0M
Property Plant And Equipment Net	633.0K	1.2M	6.1M	17.3M	19.9M	20.9M
Net Debt	(21.5M)	(91.7M)	(71.2M)	(32.5M)	(29.3M)	(30.7M)
Retained Earnings	(73.3M)	(131.7M)	(213.0M)	(286.2M)	(257.6M)	(244.7M)
Accounts Payable	395K	2.3M	8.1M	3.2M	3.6M	2.8M
Cash	24.0M	95.0M	77.6M	39.5M	45.4M	37.6M
Non Current Assets Total	1.5M	3.1M	10.1M	21.6M	24.8M	26.1M
Non Currrent Assets Other	714.5K	1.8M	3.1M	4.3M	4.9M	5.2M
Cash And Short Term Investments	24.0M	95.0M	90.9M	39.5M	45.4M	38.9M
Common Stock Total Equity	513K	527.5K	1.8M	2.0M	2.3M	2.4M
Common Stock Shares Outstanding	112.2M	195.0M	214.6M	244.3M	281.0M	295.0M
Liabilities And Stockholders Equity	27.4M	105.8M	108.6M	64.5M	74.2M	48.2M
Non Current Liabilities Total	2.2M	2.9M	6.1M	6.9M	6.2M	5.9M
Other Current Assets	1.8M	15.4M	7.6M	3.5M	4.0M	3.8M
Other Stockholder Equity	(1.7B)	225.5M	294.8M	324.1M	291.7M	306.3M
Total Liab	5.8M	9.9M	24.6M	24.0M	21.6M	18.9M
Property Plant And Equipment Gross	633.0K	1.5M	6.7M	18.5M	21.3M	22.4M
Total Current Assets	25.9M	102.6M	98.5M	43.0M	49.4M	42.0M
Common Stock	1.8M	2.0M	2.2M	2.6M	3.0M	3.1M
Short Long Term Debt Total	2.5M	3.3M	6.4M	6.9M	8.0M	8.4M
Current Deferred Revenue	2.9M	4.0M	11.2M	10.5M	12.1M	12.7M
Other Assets	474.2K	432.1K	2.0M	177K	203.6K	193.4K
Long Term Debt	1.8M	1.7M	2.3M	2.8M	3.2M	3.4M
Capital Surpluse	215.9M	62.0M	93.1M	225.5M	203.0M	137.0M
Short Term Debt	278K	726K	996K	1.5M	1.7M	1.6M
Property Plant Equipment	222.5K	1.1M	1.2M	10.0M	11.5M	12.0M
Net Tangible Assets	11.0M	21.6M	95.8M	84.1M	96.7M	101.5M
Non Current Liabilities Other	389.3K	1.2M	244K	527K	474.3K	450.6K
Net Invested Capital	23.6M	97.5M	86.3M	43.4M	49.9M	39.5M
Net Working Capital	22.3M	95.6M	80.0M	25.9M	29.8M	39.7M

When determining whether Ocugen Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Ocugen's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Ocugen Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Ocugen Inc Stock:

How To Invest In Ocugen

Details

Is Ocugen Stock a good investment?

Details

What is Ocugen's Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Ocugen Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.

You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ocugen. If investors know Ocugen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ocugen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(0.19)

Revenue Per Share

0.018

Quarterly Revenue Growth

1.353

Return On Assets

(0.48)

Return On Equity

(1.03)

The market value of Ocugen Inc is measured differently than its book value, which is the value of Ocugen that is recorded on the company's balance sheet. Investors also form their own opinion of Ocugen's value that differs from its market value or its book value, called intrinsic value, which is Ocugen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ocugen's market value can be influenced by many factors that don't directly affect Ocugen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Ocugen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Ocugen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ocugen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Ocugen Capex To Operating Cash Flow vs Ev To Sales Analysis

Capex To Operating Cash Flow vs Ev To Sales

Capex To Operating Cash Flow vs Ev To Sales Correlation Analysis

Correlation Coefficient

Capex To Operating Cash Flow

Ev To Sales

Ocugen fundamental ratios Correlations

Ocugen Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Ocugen fundamental ratios Accounts

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Property Plant And Equipment Gross	+ 1.0	Property Plant And Equipment Net
Total Current Assets	+ 1.0	Cash And Short Term Investments
Non Current Assets Total	+ 0.99	Property Plant And Equipment Net
Cash And Short Term Investments	+ 0.99	Cash
Total Current Assets	+ 0.99	Cash
Property Plant And Equipment Gross	+ 0.99	Non Current Assets Total

Cash	- 0.99	Net Debt
Cash And Short Term Investments	- 0.98	Net Debt
Total Current Assets	- 0.97	Net Debt
Net Debt	- 0.93	Total Assets
Net Debt	- 0.85	Total Stockholder Equity
Non Current Liabilities Total	- 0.82	Total Stockholder Equity